Showing 38,081 - 38,100 results of 69,285 for search '(( 01 ((1 decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 1.86s Refine Results
  1. 38081

    Table_6_Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.docx by Haiyan Zeng (3753130)

    Published 2022
    “…Compared to M0–M1a, M1b was a risk factor for OS (P = 0.01) in ED-SCLC, but not for BM (P = 0.19). …”
  2. 38082

    Table_2_Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.docx by Haiyan Zeng (3753130)

    Published 2022
    “…Compared to M0–M1a, M1b was a risk factor for OS (P = 0.01) in ED-SCLC, but not for BM (P = 0.19). …”
  3. 38083

    Table_7_Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.docx by Haiyan Zeng (3753130)

    Published 2022
    “…Compared to M0–M1a, M1b was a risk factor for OS (P = 0.01) in ED-SCLC, but not for BM (P = 0.19). …”
  4. 38084

    Table_5_Risk Factors for Brain Metastases in Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.docx by Haiyan Zeng (3753130)

    Published 2022
    “…Compared to M0–M1a, M1b was a risk factor for OS (P = 0.01) in ED-SCLC, but not for BM (P = 0.19). …”
  5. 38085

    Supplementary Material for: The Impact of the SARS-CoV-2 (COVID-19) Pandemic on Gastroenterology Training by Pisani A. (10713897)

    Published 2021
    “…Later, when the number of COVID-19-related infections decreased across Europe, the above modalities returned to normal for <50% of the trainees. …”
  6. 38086
  7. 38087
  8. 38088
  9. 38089
  10. 38090

    Effect of rPVH1-yCD/5FC treatment on NFκB and Akt/PI3K activity. by Soukaina Réjiba (445416)

    Published 2013
    “…The rPVH1-yCD/5FC treatment resulted in a significant reduction of constitutive NFκB in Panc1 (**p<0.01) and AsPc1 (***p<0.001). …”
  11. 38091
  12. 38092
  13. 38093
  14. 38094

    Table_2_Association of Circulating Magnesium Levels in Patients With Alzheimer's Disease From 1991 to 2021: A Systematic Review and Meta-Analysis.DOC by Ke Du (511486)

    Published 2022
    “…There was statistically non-significant for Mg level in CSF between AD and HCs, whereas a decreased tendency were detected (SMD = −0.16; 95% CI [−0.50, 0.18]; P = 0.364). .In addition, when we analyzed the Mg levels of serum, plasma and CSF together, the circulating Mg levels in AD patients was significantly lower (SMD = −0.74, 95% CI [−1.13; −0.35]; P = 0.000). …”
  15. 38095
  16. 38096
  17. 38097

    Video_1_Female Rats Are Resistant to Cognitive, Motor and Dopaminergic Deficits in the Reserpine-Induced Progressive Model of Parkinson’s Disease.MP4 by Alvaro C. Lima (11601898)

    Published 2021
    “…Here we investigate possible behavioral and neuronal sex differences in the effects of the repeated treatment with a low dose of reserpine in rats. Male and female Wistar rats received 10–15 injections of reserpine (0.1 mg/kg) or vehicle, on alternate days. …”
  18. 38098
  19. 38099
  20. 38100